Access to Innovative Cancer Therapies in 2010
5th Annual Oncology Economics Forum
Doubletree Philadelphia Hotel •
Philadelphia, PA
This conference has concluded, for additional information about this event and upcoming programs please contact the Confera Group at (704) 849-6934.
Issues, Challenges & Opportunities Related to Access Barriers,
Healthcare Reform and Payer Coverage Decisions in Oncology
This interactive program will enable you to hear the latest perspectives from several of the nation's top oncology thought leaders and healthcare experts regarding the most critical issues surrounding payer coverage and policy decisions impacting access to cancer care.
Now that healthcare reform has passed, many are concerned that future coverage policies for oncology therapies will negatively impact access to innovative cancer drugs and biologics. Moreover, there exists widespread uncertainty as to how the evolving U.S. healthcare system will be able to meet basic oncology healthcare needs in the future, given the expanding cost projections associated with an aging U.S. patient population and the escalating costs of new cancer therapies and treatment modalities.
The Access to Innovative Cancer Therapies in 2010 - 5th Annual Oncology Economics Forum will bring together top experts within the oncology arena to discuss how the oncology marketplace is being impacted by the rapidly changing healthcare economic environment. The Forum will highlight the most current issues that are critical to the cancer patient, the oncology provider, the payers, and the manufacturers; is designed for management and senior leadership from pharmaceutical and biotech manufacturers, oncology reimbursement consultant groups, healthcare providers, distributors, specialty pharmacies, and healthcare plans.
Given the current economic and political environment, this year’s Forum is a must attend event!
Forum Topics to Include:
Healthcare Reform: Current and Future Implications for the Oncology Marketplace
New Trends Regarding Access to New Oncology Therapies
Legislative Update and Developments Impacting Access to Cancer Care
Payer Coverage Decision Criteria & Issues Most Affecting Oncology Therapies
Oncology Provider & Payer Evidence-Based Clinical Pathway Initiatives
Global Reimbursement & Access Trends in Oncology and Potential Implications for the U.S. -
Risk-Sharing, Value-Based Pricing, Conditional Reimbursement Practices
Optimizing Oncology Brand Access: Recent Payer Analysis of Hematologic Cancer Brands
The Evolving Role of Specialty Pharmacy, Including a Comparison of Distribution Models
Hotel and Travel Arrangements
The conference is being held at the:
Doubletree Philadelpia Hotel 237 S. Broad Street Philadelphia, PA 19107-5686
For hotel reservations at the Doubletree Philadelphia Hotel, please call the hotel directly at (215) 893-1600.
Brochure & Other Documentation
Sponsors
Sponsor Information Coming Soon
|